Alexander Hampson

Lister Hospital, East and North Hertfordshire NHS Trust

Papers

7

Total Citations

414

H-Index

6

About

Alexander Hampson is a leading urological surgeon and researcher whose work centers on optimizing surgical outcomes for bladder and prostate cancer patients, with a particular focus on robotic-assisted techniques. His landmark 2022 study in JAMA, comparing robot-assisted radical cystectomy with intracorporeal urinary diversion to open surgery, has garnered over 320 citations and fundamentally shaped contemporary practice by demonstrating comparable 90-day morbidity and mortality. Hampson has also advanced the field through rigorous health economics, showing the cost-effectiveness of robotic cystectomy in a 2023 analysis. His research extends to perioperative care, including venous thromboembolism prophylaxis and the role of pneumoperitoneum pressures in reducing postoperative ileus, using novel cytokine markers to understand inflammatory responses. By analyzing national trends in over 12,000 cystectomies in England and developing real-time learning curve assessments for robotic prostatectomy, Hampson provides actionable insights for surgical training and quality improvement. His work bridges technical innovation, patient outcomes, and healthcare value, making him a pivotal figure in evidence-based robotic urologic oncology.

Research Focus

Key Achievements

6
H-Index
7
Papers
414
Total Citations
59
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer
320 citations · 2022
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 100
🏛 Institutions: Lister Hospital, East and North Hertfordshire NHS Trust

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago